WHO seeks system for tracking global clinical trials

Check, Erika
November 2004
Nature;11/11/2004, Vol. 432 Issue 7014, p137
Academic Journal
The article presents a report on a system for tracking global clinical trials. The World Health Organization (WHO) hopes to earn international support next week for a far-reaching plan to set up a global tracking system for clinical trials. These measures are intended to reduce the duplication of trials and make it easier for medical researchers, the public, journal editors and governments to track them. By taking the lead on a global registry, it also hopes to set minimum standards for what information should be included in clinical trial registries.


Related Articles

  • WHO to unveil global clinical trials register. Dyer, Owen // Bulletin of the World Health Organization;Sep2004, Vol. 82 Issue 9, p714 

    Reports that the World Health Organization will unveil the first global clinical trials register in November 2004. Criticisms on drug companies that suppressed vital data; Potential of the register to establish international procedures; Plans of the WHO to use an existing numbering system.

  • Communicating the Results of Clinical Research to Participants: Attitudes, Practices, and Future Directions. Shalowitz, David I.; Miller, Franklin G. // PLoS Medicine;May2008, Vol. 5 Issue 5, pe91 

    The authors discuss the available data on the effects of communicating aggregate and individual research results on participants, investigators, and the research enterprise.

  • Result Publication of Chinese Trials in World Health Organization Primary Registries. Liu Xuemei; Li Youping; Yin Senlin; Song Shangqi // PLoS ONE;2010, Vol. 5 Issue 9, p1 

    Background: Result publication is the key step to improve the transparency of clinical trials. Objective: To investigate the result publication rate of Chinese trials registered in World Health Organization (WHO) primary registries. Method: We searched 11 WHO primary registries for Chinese...

  • Respondent Burden in Clinical Research: When Are We Asking Too Much of Subjects? Ulrich, Connie M.; Wallen, Gwenyth R.; Feister, Autumn; Grady, Christine // IRB: Ethics & Human Research;Jul/Aug2005, Vol. 27 Issue 4, p17 

    Comments that the field of bioethics has not clearly identified or articulated the problem of respondent burden in clinical trials. Reluctance of health care providers to approach their patients for inclusion in clinical trials because of perceived distressing or burden for their patients;...

  • Wanted: People to help advance medicine. Krol, Katharine // Indianapolis Business Journal;11/22/2004, Vol. 25 Issue 37, p13A 

    Addresses the issue of the slow enrollment in clinical trials in the United States. Reasons behind the lack of enrollees in clinical trials; Impact of the trend on medical research and public health; Steps that should be taken by medical research institutions and authorities to solve the low...

  • WHO clinical trails initiative to protect the public.  // Bulletin of the World Health Organization;Jan2006, Vol. 84 Issue 1, p10 

    The article reports that World Health Organization (WHO) is developing a common set of rules for registering clinical trials. The WHO International Clinical Trials Registry Platform is a major initiative to bring clinical registers together in a global network to offer a single point of access...

  • Reporting Implementation in Randomized Trials: Proposed Additions to the Consolidated Standards of Reporting Trials Statement. Mayo-Wilson, Evan // American Journal of Public Health;Apr2007, Vol. 97 Issue 4, p630 

    Randomized controlled trials of public health interventions are often complex: practitioners may not deliver interventions as researchers intended, participants may not initiate interventions and may not behave as expected, and interventions and their effects may vary with environmental and...

  • Evidence supporting platform-switching to preserve marginal bone levels not definitive. Stafford, Gary L // Evidence-Based Dentistry;Jun2012, Vol. 13 Issue 2, p56 

    Data sourcesMEDLINE, EMBASE, The Cochrane Oral Health Group's Trials Register, The Cochrane Central Register of Controlled Trials (CENTRAL), UK National Research Register, Australian New Zealand Clinical Trials Registry (ANZCTR), Database of Abstracts of Reviews of Effectiveness (DARE), ISI...

  • Fully informed consent is impossible in surgical clinical trials. Bernstein, Mark // Canadian Journal of Surgery;Aug2005, Vol. 48 Issue 4, p271 

    This article reports that fully informed consent by patient is impossible in surgical clinical trials. Consent for an investigative procedure has 3 distinct but interrelated elements that are essentially the same as for purely therapeutic procedures: disclosure, capacity and voluntariness. It is...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics